The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow

被引：0
|
作者：
W Ingram
N C Lea
J Cervera
U Germing
P Fenaux
B Cassinat
J J Kiladjian
J Varkonyi
P Antunovic
N B Westwood
M J Arno
A Mohamedali
J Gaken
T Kontou
B H Czepulkowski
N A Twine
J Tamaska
J Csomer
S Benedek
N Gattermann
E Zipperer
A Giagounidis
Z Garcia-Casado
G Sanz
G J Mufti
机构：
[1] Kings College Hospital and Kings College London,Department of Haematological Medicine
[2] The Servicio de Hematologia y Hemoterapia,Department of Haematology
[3] Hospital Universitario La Fe,Third Department of Internal Medicine
[4] Oncology and Clinical Immunology,Department of Haematology
[5] Heinrich-Heine-University,Department of Oncology and Clinical Immunology
[6] Hematology Department at Hopital Avicenne,undefined
[7] Semmelweis University,undefined
[8] University Hospital Linköping,undefined
[9] Genomics center,undefined
[10] School of Biomedical and Health Sciences,undefined
[11] Kings College London,undefined
[12] National Health Centre,undefined
[13] Semmelweis University,undefined
[14] Institute of Pathology and Cancer Research,undefined
[15] Semmelweis University,undefined
[16] St-Johannes-Hospital,undefined
来源：
Leukemia | 2006年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1319 / 1321
页数：2
相关论文
共 50 条
  • [1] The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow
    Ingram, W.
    Lea, N. C.
    Cervera, J.
    Germing, U.
    Fenaux, P.
    Cassinat, B.
    Kiladjian, J. J.
    Varkonyi, J.
    Antunovic, P.
    Westwood, N. B.
    Arno, M. J.
    Mohamedali, A.
    Gaken, J.
    Kontou, T.
    Czepulkowski, B. H.
    Twine, N. A.
    Tamaska, J.
    Csomer, J.
    Benedek, S.
    Gattermann, N.
    Zipperer, E.
    Giagounidis, A.
    Garcia-Casado, Z.
    Sanz, G.
    Mufti, G. J.
    LEUKEMIA, 2006, 20 (07) : 1319 - 1321
  • [2] RARE MDS/MPN OVERLAP: WHEN JAK2 V617F MEETS DEL(5Q) MUTATION
    Rupoli, S.
    Morsia, E.
    Goteri, G.
    Capelli, D.
    Scortechini, A. R.
    Poloni, A.
    Micucci, G.
    Garvey, K. B.
    Ceglie, S.
    Fiorentini, A.
    Angelini, M.
    Mancini, S.
    Discepoli, G.
    Viola, N.
    Olivieri, A.
    HAEMATOLOGICA, 2019, 104 : 170 - 170
  • [3] Response to lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2 V617F mutation
    Azaceta, Gemma
    Calasanz, Maria J.
    Dourdil, Victoria
    Bonafonte, Elena
    Izquierdo, Isabel
    Palomera, Luis
    LEUKEMIA & LYMPHOMA, 2010, 51 (10) : 1941 - 1943
  • [4] The JAK2 V617F mutation identifies specific subgroups of myelodysplastic syndrome (MDS).
    Ceesay, M. Mansour
    Lea, Nicholas
    Ingram, Wendy C.
    Cervera, Jose
    Germing, Ulrich
    Fenaux, Pierre
    Cassinat, Bruno
    Kiladjian, Jean-Jacques
    Varkonyi, Judith
    Antunovic, Petar
    Westwood, Nigel B.
    Arno, Matthew J.
    Mohamedali, Azim
    Gaken, Joop
    Twine, Natalie
    Gattermann, Norbert
    Giagounidis, Aristotoles
    Garcia-Casado, Zaida
    Sanz, Guillermo
    Mufti, Ghulam J.
    BLOOD, 2006, 108 (11) : 737A - 737A
  • [5] THE JAK2 V617F MUTATION IN ISOLATED NEUTROPENIA
    Langabeer, Stephen E.
    EXCLI JOURNAL, 2018, 17 : 1 - 2
  • [6] The JAK2 V617F mutation in patients with anaemia
    S. E. Langabeer
    Irish Journal of Medical Science (1971 -), 2017, 186 : 349 - 350
  • [7] Durable response to lenalidomide in a patient with myelodysplastic syndrome associated with isolated 5q deletion and JAK2 V617F mutation despite discontinuation of treatment
    Hatzimichael, Eleftheria
    Lagos, Konstantinos
    Vassou, Amalia
    Gougopoulou, Dora
    Papoudou-Bai, Alexandra
    Briasoulis, Evangelos
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (01) : 23 - 26
  • [8] The JAK2 V617F mutation in patients with anaemia
    Langabeer, S. E.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (02) : 349 - 350
  • [9] JAK2 V617F mutation is infrequent in "5q-syndrorne" and 5q-associated MDS.
    Zhang, Ling
    Gueller, Saskia
    Raynaud, Sophie
    Koeffler, Phillip H.
    Lee, Stephen
    BLOOD, 2006, 108 (11) : 293B - 293B
  • [10] Detecting the JAK2 V617F mutation in fresh and ‘historic’ blood and bone marrow
    S Gattenlohner
    C Peter
    M Bonengel
    H Einsele
    R Bargou
    H-K Müller-Hermelink
    A Marx
    Leukemia, 2007, 21 : 1599 - 1602
12345